Drug interactions
Insulin glargine-lixisenatide + Potassium citrate
Severity: Minor
Insulin glargine-lixisenatide and Potassium citrate: minor interaction.
Last updated
For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.
Summary
Insulin drives potassium into cells and can lower serum potassium, so the effect is generally opposite to what potassium supplementation aims to achieve. Potassium replacement is typically needed alongside insulin in significant hypokalemia, and it does not cause a harmful interaction at usual doses.
What this interaction means in plain words
Insulin glargine-lixisenatide and Potassium citrate have a small, usually unimportant interaction. Most people can take both; the pharmacist may still mention it so that any unexpected effect is recognised.
Insulin glargine-lixisenatide belongs to Endocrine; Potassium citrate belongs to Gastrointestinal Tract.
Why it happens
Insulin promotes cellular potassium uptake, which counteracts the serum potassium raised by supplementation.
What to do
Monitor serum potassium when insulin is started or adjusted in patients receiving potassium supplements, and adjust supplementation to the measured level.
What to ask your pharmacist
- Is there anything I should notice while taking both?
- Do I need to tell my doctor at the next visit?
Pro+ members
Unlock the full page
Create an account and start a Pro+ trial to unlock the full management advice for Insulin glargine-lixisenatide and Potassium citrate, the additional notes, the evidence detail and the whole-prescription interaction checker.
- Full clinical management advice
- Additional notes
- Evidence detail
- Interaction checker for a whole prescription
Try Pro+ free for 7 days on the web. No card needed.
Other interactions of Insulin glargine-lixisenatide
- Albiglutide + Insulin glargine-lixisenatide Major
- Chlorpropamide + Insulin glargine-lixisenatide Major
- Dulaglutide + Insulin glargine-lixisenatide Major
- Ethanol + Insulin glargine-lixisenatide Major
- Exenatide injectable + Insulin glargine-lixisenatide Major
- Glimepiride + Insulin glargine-lixisenatide Major
Other interactions of Potassium citrate
Frequently asked questions
Can I take Insulin glargine-lixisenatide with Potassium citrate?
MediHelp rates the interaction as minor. Insulin glargine-lixisenatide and Potassium citrate have a small, usually unimportant interaction. Most people can take both; the pharmacist may still mention it so that any unexpected effect is recognised. Insulin drives potassium into cells and can lower serum potassium, so the effect is generally opposite to what potassium supplementation aims to achieve. Potassium replacement is typically needed alongside insulin in significant hypokalemia, and it does not cause a harmful interaction at usual doses.
How serious is the interaction between Insulin glargine-lixisenatide and Potassium citrate?
MediHelp rates it minor, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Monitor serum potassium when insulin is started or adjusted in patients receiving potassium supplements, and adjust supplementation to the measured level.
What other medicines interact with Insulin glargine-lixisenatide?
MediHelp also lists interactions of Insulin glargine-lixisenatide with, for example, Albiglutide, Chlorpropamide, Dulaglutide. The full list is on the Insulin glargine-lixisenatide page.
Full monographs, dosing and an interaction checker in the MediHelp app
Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.
